EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes

Melody B Hancock, Dana R Ruby, Rachael A Bieler, D Chris Cole, Kurt C Marsden iD

Disease Models & Mechanisms · 2026

DOI: 10.1242/dmm.052592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Disease Models & Mechanisms, 2026. Verfasst von Melody B Hancock und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, North Carolina State University, Raleigh, NC 27607, USA. Hauptthemen laut MEDLINE: CHARGE Syndrome, Zebrafish, DNA-Binding Proteins, Zebrafish Proteins. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, North Carolina State University, National Institute of Neurological Disorders and Stroke.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

CHARGE syndrome is a developmental disorder that affects 1 in 10,000 births, and patients exhibit both physical and behavioral characteristics. De novo mutations in CHD7 (chromodomain helicase DNA binding protein 7) cause 67% of CHARGE syndrome cases. CHD7 is a DNA-binding chromatin remodeler with thousands of predicted binding sites in the genome, making it challenging to define molecular pathways linking loss of CHD7 to CHARGE phenotypes. To address this problem, here we used a previously characterized zebrafish CHARGE model to generate transcriptomic and proteomic datasets from larval zebrafish head tissue at two developmental time points. By integrating these datasets with differential expression, pathway, and upstream regulator analyses, we identified multiple consistently dysregulated pathways and defined a set of candidate genes that link loss of chd7 with disease-related phenotypes. Finally, to functionally validate the roles of these genes, CRISPR/Cas9-mediated knockdown of capgb, nefla, or rdh5 phenocopies behavioral defects seen in chd7 mutants. Our data provide a resource for further investigation of molecular mediators of CHD7 and a template to reveal functionally relevant therapeutic targets to alleviate specific aspects of CHARGE syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CHARGE SyndromeZebrafishDNA-Binding ProteinsZebrafish ProteinsMultiomicsDNA HelicasesAnimalsPhenotypeDisease Models, AnimalProteomicsGene Knockdown TechniquesGene Expression Regulation, DevelopmentalTranscriptomeCRISPR-Cas Systems

Stichwörter der Autor:innen

BehaviorCHARGE syndromeCHD7Developmental disorderProteomicsTranscriptomics

Substanzen

DNA-Binding ProteinsZebrafish ProteinsChd7 protein, zebrafishDNA Helicases

Autor:innen und Institutionen

  • Department of Biological Sciences, North Carolina State University, Raleigh, NC 27607, USA.

ORCID-Profile: Kurt C Marsden

Förderung

  • NINDS NIH HHS
  • North Carolina State University
  • National Institute of Neurological Disorders and Stroke

Zitieren

APA

Hancock, M. B., Ruby, D. R., Bieler, R. A., Cole, D. C., & Marsden, K. C. (2026). Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes. Disease Models & Mechanisms. https://doi.org/10.1242/dmm.052592

Vancouver

Hancock MB, Ruby DR, Bieler RA, Cole DC, Marsden KC. Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes. Disease Models & Mechanisms. 2026. doi:10.1242/dmm.052592

BibTeX
@article{Hancock2026,
  author = {Hancock, Melody B and Ruby, Dana R and Bieler, Rachael A and Cole, D Chris and Marsden, Kurt C},
  title = {Multi-omic analyses identify molecular targets of Chd7 that contribute to CHARGE syndrome model phenotypes},
  journal = {Disease Models & Mechanisms},
  year = {2026},
  doi = {10.1242/dmm.052592}
}
Kostenlos starten →